Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic myopathies

I Tein1

  • 1Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.

Seminars in Pediatric Neurology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Metabolic disorders affecting glycogen, lipid, or mitochondrial function can lead to progressive muscle weakness or exercise-induced muscle dysfunction. These conditions, including glycogenoses and fatty acid oxidation defects, impact muscle health and performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebral hyperperfusion and decreased cerebrovascular reactivity correlate with neurologic disease severity in MELAS.

Mitochondrion·2015
Same author

OCTN2 mutation (R254X) found in Saudi Arabian kindred: recurrent mutation or ancient founder mutation?

Journal of inherited metabolic disease·2004
Same author

Diagnostic difficulties in a case of primary systemic carnitine deficiency with idiopathic dilated cardiomyopathy.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2004
Same author

Carnitine transport: pathophysiology and metabolism of known molecular defects.

Journal of inherited metabolic disease·2003
Same author

Glucose-free medium exacerbates microvesicular steatosis in cultured skin fibroblasts of genetic defects of fatty acid oxidation. A novel screening test.

Journal of inherited metabolic disease·2003
Same author

Maternally inherited hypertrophic cardiomyopathy: a manifestation of mitochondrial DNA mutations--clinical course in two families.

Pediatric cardiology·2000
Same journal

Concussion in contact sport: risks, detection, & prevention.

Seminars in pediatric neurology·2026
Same journal

A multidisciplinary, symptom-targeted approach to rehabilitation in pediatric concussion.

Seminars in pediatric neurology·2026
Same journal

Pediatric concussion beyond sports: Falls, play, and everyday activities.

Seminars in pediatric neurology·2026
Same journal

Return-to-school protocols in pediatric concussion care.

Seminars in pediatric neurology·2026
Same journal

Improving concussion recognition in youth sports: the role of parents, coaches, and community education.

Seminars in pediatric neurology·2026
Same journal

Concussion management, rehabilitation, and societal impact.

Seminars in pediatric neurology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Muscle Physiology

Background:

  • Disorders of glycogen, lipid, or mitochondrial metabolism are associated with significant neuromuscular manifestations.
  • These metabolic myopathies can present with distinct clinical syndromes, affecting muscle strength and exercise capacity.

Purpose of the Study:

  • To categorize the clinical syndromes arising from defects in glycogen, lipid, or mitochondrial metabolism.
  • To highlight the diverse range of muscle dysfunction associated with these metabolic disorders.

Main Methods:

  • Review of clinical presentations associated with specific enzyme deficiencies in glycogenosis, fatty acid oxidation, and mitochondrial metabolism.
  • Classification of disorders based on primary clinical phenotypes: progressive weakness versus acute exercise intolerance.

Related Experiment Videos

Main Results:

  • Two primary clinical syndromes were identified: progressive muscle weakness and acute, reversible muscle dysfunction with exercise intolerance.
  • Specific examples of enzyme deficiencies within glycogenoses, fatty acid oxidation defects, and mitochondrial disorders were linked to each syndrome.
  • Myoadenylate deaminase deficiency was noted as a purine nucleotide cycle defect causing exercise-related cramps.

Conclusions:

  • Defects in key metabolic pathways (glycogen, lipid, mitochondrial) manifest in predictable patterns of muscle disease.
  • Understanding these patterns aids in diagnosing and managing patients with metabolic myopathies.
  • Further research may clarify the role of myoadenylate deaminase deficiency in exercise-related muscle symptoms.